MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

Search

Integra LifeSciences Holdings Corp

Suletud

SektorTervishoid

16.7 2.58

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

15.7

Max

16.91

Põhinäitajad

By Trading Economics

Sissetulek

30M

19M

Müük

62M

443M

P/E

Sektori keskmine

63.02

57.333

Aktsiakasum

0.97

Kasumimarginaal

4.391

Töötajad

4,396

EBITDA

40M

79M

Soovitused

By TipRanks

Soovitused

Neutraalne

12 kuu keskmine prognoos

+47.31% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

5. mai 2025

Turustatistika

By TradingEconomics

Turukapital

-819M

1.2B

Eelmine avamishind

14.12

Eelmine sulgemishind

16.7

Tehniline skoor

By Trading Central

Kindlus

Strong Bullish Evidence

Integra LifeSciences Holdings Corp Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

6. mai 2024, 16:47 UTC

Tulu
Suurimad hinnamuutused turgudel

Integra LifeSciences Shares Drop to Record Low on Unexpected Loss, Boston Facility Audit Findings

Võrdlus sarnastega

Hinnamuutus

Integra LifeSciences Holdings Corp Prognoos

Hinnasiht

By TipRanks

47.31% tõus

12 kuu keskmine prognoos

Keskmine 24.6 USD  47.31%

Kõrge 35 USD

Madal 19 USD

Põhineb 6 Wall Streeti analüütiku instrumendi Integra LifeSciences Holdings Corp 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

6 ratings

2

Osta

2

Hoia

2

Müü

Tehniline skoor

By Trading Central

15.67 / 17.29Toetus ja vastupanu

Lühikene perspektiiv

Strong Bullish Evidence

Keskpikk perspektiiv

Very Strong Bearish Evidence

Pikk perspektiiv

Bearish Evidence

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Integra LifeSciences Holdings Corp

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.